A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including
German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic can
Germany's Ada Health has added another $30 million to its second-round financing first announced last year, saying it will use the new cash to strengthen its presence in the US market.